Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (LLY)
NYSE:LLY
LLY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$711.40 - $972.53
Previous CloseN/A
Volume1.27M
Average Volume (3M)3.91M
Market Cap
$813.75B
Enterprise Value$829.46B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)73.2
Beta0.62
Next Earnings
May 01, 2025EPS Estimate
4.7Last Dividend Ex-Date
Feb 14, 2025Dividend Yield0.61%
Share Statistics
EPS (TTM)11.72
Shares Outstanding949,315,700
10 Day Avg. Volume3,687,149
30 Day Avg. Volume3,911,284
Standard Deviation0.09
R-Squared0.06
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)19.91
Price to Cash Flow (P/CF)54.80
P/FCF Ratio86.20
Enterprise Value/Market Cap1.02
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit22.65
Enterprise Value/Ebitda53.07
Forecast
1Y Price Target
$1,015.85Price Target Upside17.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
---
Bulls Say, Bears Say
Bulls Say
Drug DevelopmentPhase 3 trials from oral weight loss drug Orforglipron expected to boost Lilly's share price.
Market ExpansionMounjaro has been successfully launched in all major European markets and is expanding in China.
Bears Say
Pricing RisksLilly saw volatile share price movements due to Biden proposing Medicare and Medicaid coverage of obesity drugs, which could put Tirzepatide sales at risk of harsh price cuts in the US.
---
Ownership Overview
10.33% Insiders
22.65% Mutual Funds
27.58% Other Institutional Investors
23.58% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LLY FAQ
What was Eli Lilly & Co’s price range in the past 12 months?
Eli Lilly & Co lowest stock price was $711.40 and its highest was $972.53 in the past 12 months.
What is Eli Lilly & Co’s market cap?
Eli Lilly & Co’s market cap is $813.75B.
When is Eli Lilly & Co’s upcoming earnings report date?
Eli Lilly & Co’s upcoming earnings report date is May 01, 2025 which is in 69 days.
How were Eli Lilly & Co’s earnings last quarter?
Eli Lilly & Co released its earnings results on Feb 06, 2025. The company reported $5.32 earnings per share for the quarter, beating the consensus estimate of $5.045 by $0.275.
Is Eli Lilly & Co overvalued?
According to Wall Street analysts Eli Lilly & Co’s price is currently Undervalued.
Does Eli Lilly & Co pay dividends?
Eli Lilly & Co pays a Quarterly dividend of $1.5 which represents an annual dividend yield of 0.61%. See more information on Eli Lilly & Co dividends here
What is Eli Lilly & Co’s EPS estimate?
Eli Lilly & Co’s EPS estimate is 4.7.
How many shares outstanding does Eli Lilly & Co have?
Eli Lilly & Co has 949,315,700 shares outstanding.
What happened to Eli Lilly & Co’s price movement after its last earnings report?
Eli Lilly & Co reported an EPS of $5.32 in its last earnings report, beating expectations of $5.045. Following the earnings report the stock price went up 3.347%.
Which hedge fund is a major shareholder of Eli Lilly & Co?
Currently, no hedge funds are holding shares in LLY
---
Eli Lilly & Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1,015.85 (17.16% Upside)
$1,015.85 (17.16% Upside)
Blogger Sentiment
Bullish
LLY Sentiment 84%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 285.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $223.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.3%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.58%
12-Months-Change
Fundamentals
Return on Equity
73.95%
Trailing 12-Months
Asset Growth
30.55%
Trailing 12-Months
Company Description
Eli Lilly & Co
Founded in 1876, Eli Lilly & Co. is a leading healthcare company that manufactures and sells pharmaceutical products worldwide. The company is headquartered in Indianapolis, Indiana.
---
LLY Company Deck
---
LLY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and successful product launches, underpinned by strategic investments and advancements in the pipeline. However, challenges such as pricing pressures, a decline in Trulicity revenue, and supply constraints in certain regions tempered the overall positive outlook.Read More>---
LLY Revenue Breakdown
67.44% U.S.
15.36% Europe
9.48% ROW
4.03% Japan
3.69% China
---
LLY Stock 12 Month Forecast
Average Price Target
$1,015.85
▲(17.16% Upside)
Technical Analysis
Best Analysts Covering LLY
1 Year
1 Year Success Rate
33/35 ratings generated profit
1 Year Average Return
+40.12%
reiterated a buy rating last month
Copying Chris Schott's trades and holding each position for 1 Year would result in 94.29% of your transactions generating a profit, with an average return of +40.12% per trade.
---